GO
Loading...

Latest Video

Contact Latest Video

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Video and TV

Wednesday, 23 Apr 2014 | 9:19 AM ET

Activist investor Carl Icahn comments on Bill Ackman's role in the Valeant Pharmaceuticals bid for Allergan. The "Squawk on the Street" team provide insight.

Wednesday, 23 Apr 2014 | 9:17 AM ET

The "Squawk on the Street" news team discuss the involvement of Bill Ackman in the deal between Valeant Pharmaceuticals and Allergan.

Wednesday, 23 Apr 2014 | 7:48 AM ET

William Ackman, Pershing Square Capital Management, explains how his partnership with Valeant is structured. And J. Michael Pearson, Valeant chairman & CEO, discusses why he partnered with Ackman instead of pursing Allergan alone. Creating shareholder value is our job, says Pearson.

U.S. Video

  • CNBC's Cadie Thompson discusses how analysts aren't expecting any big surprises from the Microsoft earnings report, but that if there's going to be anything to watch out for, it will most likely be from the Windows business.

  • Vocalist Fergie of The Black Eyed Peas is on the floor at the NYSE to ring the closing bell.

  • Coca-Cola's board of directors responds to Warren Buffett's opposition to its equity plan, reports CNBC's Sara Eisen.

Asia Video

Europe Video

Most Popular Video

Wednesday, 23 Apr 2014 | 1:00 PM ET

CNBC's Kelli Grant talks about the types of protection available to credit and debit card holders in the transition to a cashless society.

Wednesday, 23 Apr 2014 | 12:00 PM ET

Rumors of a delayed Apple iPhone 6 product launch and a larger display screen are swirling about the technosphere, with Lindsey Turrentine, CNET editor-in-chief.

Wednesday, 23 Apr 2014 | 11:40 AM ET

CNBC's Bob Pisani and Art Cashin, of UBS, discuss anticipation for Apple and Facebook's earnings, and the yield on the 10-year Treasury yield.